Can prednisone (corticosteroid) and colchicine be administered concurrently for gout flare treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, prednisone and colchicine can be taken concurrently for gout treatment

Both the 2012 American College of Rheumatology and 2017 EULAR guidelines explicitly endorse the combination of oral corticosteroids and colchicine as an acceptable and appropriate treatment approach for acute gout flares, particularly in severe cases involving multiple large joints or polyarticular arthritis. 1

When Combination Therapy is Recommended

The concurrent use of prednisone and colchicine is specifically indicated for:

  • Acute, severe gout attacks with involvement of multiple large joints or polyarticular arthritis 1
  • Inadequate response to monotherapy - adding a second agent when initial single-drug therapy doesn't provide sufficient relief 1
  • Prophylaxis during urate-lowering therapy initiation - low-dose prednisone (<10 mg/day) can be used as second-line prophylaxis when colchicine is contraindicated or not tolerated 1

Dosing for Combination Therapy

When using both medications together:

For acute flare treatment:

  • Prednisone: 0.5 mg/kg per day (typically 30-35 mg/day) for 5-10 days at full dose, then stop OR taper over 7-10 days 1
  • Colchicine: Either full treatment dose (1.2 mg followed by 0.6 mg one hour later) OR prophylaxis dose (0.5-1 mg/day) 1

For prophylaxis during urate-lowering therapy:

  • Low-dose prednisone: <10 mg/day (second-line option when colchicine/NSAIDs contraindicated) 1
  • Low-dose colchicine: 0.5-1 mg/day (first-line prophylaxis) 2

Critical Safety Considerations

Drug Interactions with Colchicine

Colchicine should NOT be given concurrently with strong P-glycoprotein and/or CYP3A4 inhibitors (such as cyclosporin or clarithromycin), as this significantly increases colchicine plasma levels and risk of fatal toxicity 2, 3. If patients are on these medications, colchicine doses must be drastically reduced or avoided entirely.

Renal Impairment

  • Severe renal impairment (CrCl <30 mL/min): Colchicine should be avoided 2. If used, start at 0.3 mg/day with careful monitoring 3
  • Both colchicine and NSAIDs should be avoided in severe renal impairment 2
  • Prednisone becomes the preferred option in this population

Gastrointestinal Toxicity

Important caveat: While the combination is endorsed, one case report suggests that initial treatment with NSAIDs or corticosteroids may potentially increase colchicine toxicity through pharmacokinetic and pharmacodynamic interactions in the gut wall 4. Patients with underlying diverticular disease may be at particular risk. Monitor closely for diarrhea, which is the first symptom of colchicine poisoning - if this occurs, reduce the colchicine dose immediately 5.

What Was NOT Recommended

The ACR task force panel was not asked to vote on combining NSAIDs with systemic corticosteroids due to concerns about synergistic gastrointestinal tract toxicity 1. This combination should be avoided.

Clinical Algorithm

For severe acute gout flare:

  1. Check for contraindications to both agents (renal function, drug interactions, infection)
  2. If no contraindications → Use full-dose prednisone (30-35 mg/day) + colchicine (1.2 mg then 0.6 mg one hour later)
  3. Continue prednisone for 5-10 days, then stop or taper
  4. Monitor for diarrhea (colchicine toxicity) and adjust dose accordingly

For prophylaxis during ULT initiation:

  1. First-line: Colchicine 0.5-1 mg/day alone
  2. If colchicine contraindicated/not tolerated → Low-dose prednisone (<10 mg/day)
  3. Continue for at least 6 months 2, 6

The combination is safe and effective when used appropriately with attention to contraindications and drug interactions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.